• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

膀胱癌患者血清中巨噬细胞移动抑制因子-抗凝血酶 III 复合物减少：复合物形成作为失活机制。

Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.

机构信息

Bay Pines VA Healthcare System, Research and Development, Bay Pines, FL 33744, USA.

出版信息

Cancer Lett. 2010 Apr 1;290(1):49-57. doi: 10.1016/j.canlet.2009.08.025. Epub 2009 Sep 16.

DOI:10.1016/j.canlet.2009.08.025
PMID:19762145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832085/
Abstract

Mounting evidence suggests that the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) may serve as an important link between chronic inflammation and carcinogenesis as evidenced by the increase in serum MIF found in patients with various cancers. The present study identifies anti-thrombin III (ATIII) as an endogenous MIF binding protein, which reduces MIF biological activity. Serum MIF in bladder cancer patients (TCC stage II, n=50) was increased when compared to normal patients (n=50), while ATIII-MIF complexes were decreased in bladder cancer patient serum. These data suggest that increased circulating levels of bioactive MIF are present in bladder cancer patient serum.

摘要

越来越多的证据表明，促炎细胞因子巨噬细胞移动抑制因子（MIF）可能是慢性炎症与癌变之间的重要联系，这表现在各种癌症患者血清中发现的 MIF 水平升高。本研究发现抗凝血酶 III（ATIII）是 MIF 的内源性结合蛋白，可降低 MIF 的生物学活性。与正常患者（n=50）相比，膀胱癌患者（TCC Ⅱ期，n=50）的血清 MIF 增加，而膀胱癌患者血清中的 ATIII-MIF 复合物减少。这些数据表明，膀胱癌患者血清中存在循环生物活性 MIF 水平升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/6137e94dfb00/nihms146096f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/c140a589ddc5/nihms146096f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/82f8f5ffa9db/nihms146096f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/d281ef7d8eb1/nihms146096f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/153b22db1e94/nihms146096f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/6137e94dfb00/nihms146096f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/c140a589ddc5/nihms146096f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/82f8f5ffa9db/nihms146096f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/d281ef7d8eb1/nihms146096f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/153b22db1e94/nihms146096f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd13/2832085/6137e94dfb00/nihms146096f5.jpg

相似文献

1
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.膀胱癌患者血清中巨噬细胞移动抑制因子-抗凝血酶 III 复合物减少：复合物形成作为失活机制。
Cancer Lett. 2010 Apr 1;290(1):49-57. doi: 10.1016/j.canlet.2009.08.025. Epub 2009 Sep 16.
2
[Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].巨噬细胞移动抑制因子在膀胱尿路上皮癌中的表达及意义
Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):28-31.
3
Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance.通过叶酸受体α配体靶向PCR对膀胱移行细胞癌中罕见循环肿瘤细胞进行定量分析及其潜在诊断意义。
Tumour Biol. 2014 Jul;35(7):7217-23. doi: 10.1007/s13277-014-1894-0. Epub 2014 Apr 27.
4
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells.巨噬细胞迁移抑制因子的抑制作用可降低膀胱癌细胞的增殖和细胞因子表达。
BMC Cancer. 2004 Jul 12;4:34. doi: 10.1186/1471-2407-4-34.
5
Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine.巨噬细胞移动抑制因子在尿路感染患者尿液中升高：人尿液中的巨噬细胞移动抑制因子-蛋白质复合物
J Urol. 2006 Apr;175(4):1523-8. doi: 10.1016/S0022-5347(05)00650-6.
6
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.巨噬细胞移动抑制因子（MIF）在胃癌中上皮及血清表达增加：MIF在胃癌发生中的潜在作用
Gut. 2006 Jun;55(6):797-802. doi: 10.1136/gut.2005.078113. Epub 2006 Feb 17.
7
The role of serum laminin P1 in the diagnosis of transitional cell carcinoma of the bladder.血清层粘连蛋白P1在膀胱移行细胞癌诊断中的作用。
Eur Urol. 1992;21(3):240-4. doi: 10.1159/000474846.
8
Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.膀胱移行细胞癌患者血清样本中CDH13启动子甲基化的临床意义
J Int Med Res. 2011;39(1):179-86. doi: 10.1177/147323001103900119.
9
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.巨噬细胞移动抑制因子（MIF）的无效突变与小鼠侵袭性较低的膀胱癌有关。
BMC Cancer. 2007 Jul 24;7:135. doi: 10.1186/1471-2407-7-135.
10
Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis.巨噬细胞移动抑制因子通过促进增殖和血管生成促进膀胱癌的进展。
Carcinogenesis. 2013 Dec;34(12):2891-9. doi: 10.1093/carcin/bgt239. Epub 2013 Jul 3.

引用本文的文献

1
Decreased serpin C1 in extracellular vesicles predicts response to methotrexate treatment in patients with pulmonary sarcoidosis.细胞外囊泡中丝氨酸蛋白酶抑制剂 C1 的减少可预测肺结节病患者对甲氨蝶呤治疗的反应。
Respir Res. 2024 Apr 16;25(1):166. doi: 10.1186/s12931-024-02809-y.
2
Pleiotropic role of macrophage migration inhibitory factor in cancer.巨噬细胞移动抑制因子在癌症中的多效性作用
Am J Cancer Res. 2019 Dec 1;9(12):2760-2773. eCollection 2019.
3
Informative gene selection and the direct classification of tumors based on relative simplicity.

本文引用的文献

1
Substance P increases cell-surface expression of CD74 (receptor for macrophage migration inhibitory factor): in vivo biotinylation of urothelial cell-surface proteins.P物质增加CD74（巨噬细胞迁移抑制因子受体）的细胞表面表达：尿路上皮细胞表面蛋白的体内生物素化。
Mediators Inflamm. 2009;2009:535348. doi: 10.1155/2009/535348. Epub 2009 Mar 22.
2
A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.一种缺乏互变异构酶的巨噬细胞迁移抑制因子（MIF）基因敲入小鼠模型显示，是蛋白质相互作用而非酶活性介导了MIF依赖的生长调节。
Mol Cell Biol. 2009 Apr;29(7):1922-32. doi: 10.1128/MCB.01907-08. Epub 2009 Feb 2.
3
基于相对简易性的信息性基因选择与肿瘤的直接分类
BMC Bioinformatics. 2016 Jan 20;17:44. doi: 10.1186/s12859-016-0893-0.
4
Thrombin induces macrophage migration inhibitory factor release and upregulation in urothelium: a possible contribution to bladder inflammation.凝血酶诱导尿路上皮细胞释放巨噬细胞移动抑制因子并使其上调：可能有助于膀胱炎症。
PLoS One. 2010 Dec 31;5(12):e15904. doi: 10.1371/journal.pone.0015904.
5
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.伊布地特对巨噬细胞移动抑制因子的变构抑制作用。
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11313-8. doi: 10.1073/pnas.1002716107. Epub 2010 Jun 8.
Many cytokines are very useful therapeutic targets in disease.
许多细胞因子是疾病中非常有用的治疗靶点。
J Clin Invest. 2008 Nov;118(11):3533-6. doi: 10.1172/JCI37346.
4
Thrombin induced secretion of macrophage migration inhibitory factor (MIF) and its effect on nuclear signaling in endothelium.凝血酶诱导巨噬细胞移动抑制因子（MIF）的分泌及其对内皮细胞核信号传导的影响。
J Cell Biochem. 2008 Dec 1;105(5):1279-88. doi: 10.1002/jcb.21928.
5
Role of MIF in inflammation and tumorigenesis.巨噬细胞移动抑制因子在炎症和肿瘤发生中的作用。
Oncology. 2008;75(3-4):127-33. doi: 10.1159/000155223. Epub 2008 Sep 15.
6
Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection.巨噬细胞移动抑制因子：在炎症性疾病和移植排斥反应中的作用
Inflamm Res. 2008 Feb;57(2):45-50. doi: 10.1007/s00011-007-7110-6.
7
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.巨噬细胞移动抑制因子（MIF）是自身免疫性糖尿病进展所必需的。
J Cell Physiol. 2008 Jun;215(3):665-75. doi: 10.1002/jcp.21346.
8
2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins.肺鳞状细胞癌与正常血清的二维差异凝胶电泳显示十种特定蛋白质水平存在一致变化。
Electrophoresis. 2007 Dec;28(23):4302-10. doi: 10.1002/elps.200700246.
9
Regulatory pathways in inflammation.炎症中的调节通路。
Autoimmun Rev. 2007 Nov;7(1):8-11. doi: 10.1016/j.autrev.2007.03.002. Epub 2007 Mar 26.
10
High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats.高剂量抗凝血酶III可抑制高迁移率族蛋白B1，并改善内毒素诱导的大鼠急性肺损伤。
Intensive Care Med. 2008 Feb;34(2):361-7. doi: 10.1007/s00134-007-0887-5. Epub 2007 Oct 17.